HomeCompareSKKAF vs GBDC

SKKAF vs GBDC: Dividend Comparison 2026

SKKAF yields 1.21% · GBDC yields 11.85%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GBDC wins by $17.47M in total portfolio value
10 years
SKKAF
SKKAF
● Live price
1.21%
Share price
$66.37
Annual div
$0.80
5Y div CAGR
92.9%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3.31M
Annual income
$2,691,913.10
Full SKKAF calculator →
GBDC
GBDC
● Live price
11.85%
Share price
$12.66
Annual div
$1.50
5Y div CAGR
51.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.78M
Annual income
$16,389,263.41
Full GBDC calculator →

Portfolio growth — SKKAF vs GBDC

📍 GBDC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSKKAFGBDC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SKKAF + GBDC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SKKAF pays
GBDC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SKKAF
Annual income on $10K today (after 15% tax)
$102.52/yr
After 10yr DRIP, annual income (after tax)
$2,288,126.14/yr
GBDC
Annual income on $10K today (after 15% tax)
$1,007.11/yr
After 10yr DRIP, annual income (after tax)
$13,930,873.90/yr
At 15% tax rate, GBDC beats the other by $11,642,747.76/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SKKAF + GBDC for your $10,000?

SKKAF: 50%GBDC: 50%
100% GBDC50/50100% SKKAF
Portfolio after 10yr
$12.04M
Annual income
$9,540,588.25/yr
Blended yield
79.23%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on GBDC right now

SKKAF
No analyst data
Altman Z
5.7
Piotroski
3/9
GBDC
Analyst Ratings
6
Buy
5
Hold
Consensus: Buy
Price Target
$14.00
+10.6% upside vs current
Range: $13.00 — $15.00
Altman Z
0.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SKKAF buys
0
GBDC buys
2
PoliticianChamberTickerTypeAmountDate
David P. Joyce🏢 House$GBDC▼ Sell$1,001 - $15,0002023-06-30
David P. Joyce🏢 House$GBDC▼ Sell$15,001 - $50,0002023-06-19
David P. Joyce🏢 House$GBDC▼ Sell$15,001 - $50,0002022-07-14
David P. Joyce🏢 House$GBDC▼ Sell$15,001 - $50,0002022-07-12
Teresa Leger Fernandez🏢 House$GBDC▼ Sell$15,001 - $50,0002021-01-20
David P. Joyce🏢 House$GBDC▲ Buy$1,001 - $15,0002020-02-25
David P. Joyce🏢 House$GBDC▲ Buy$15,001 - $50,0002019-05-30
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSKKAFGBDC
Forward yield1.21%11.85%
Annual dividend / share$0.80$1.50
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR92.9%51.1%
Portfolio after 10y$3.31M$20.78M
Annual income after 10y$2,691,913.10$16,389,263.41
Total dividends collected$3.23M$20.36M
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: SKKAF vs GBDC ($10,000, DRIP)

YearSKKAF PortfolioSKKAF Income/yrGBDC PortfolioGBDC Income/yrGap
1← crossover$10,933$232.67$12,490$1,790.28$1.6KGBDC
2$12,157$458.57$16,522$3,157.73$4.4KGBDC
3$13,927$919.26$23,578$5,898.68$9.7KGBDC
4$16,800$1,898.57$37,115$11,886.75$20.3KGBDC
5$22,105$4,128.96$66,136$26,423.57$44.0KGBDC
6$33,447$9,794.19$137,257$66,491.44$103.8KGBDC
7$62,504$26,716.32$341,734$194,868.54$279.2KGBDC
8$156,888$90,008.11$1,050,788$685,133.02$893.9KGBDC
9$575,165$407,295.06$4,099,314$2,974,971.01$3.52MGBDC
10$3,307,340$2,691,913.10$20,775,530$16,389,263.41$17.47MGBDC

SKKAF vs GBDC: Complete Analysis 2026

SKKAFStock

Sk Kaken Co.,Ltd. manufactures and sells organic and inorganic water-based coating materials, synthetic resin paints, inorganic coating materials, and inorganic building materials in Japan and internationally. It is also involved in the contracting of special finishing works and fireproof insulation works; and manufacture and sale of heat insulation materials, fireproof coating materials, and fireproof paints, as well as various chemical products. In addition, the company's products include exterior finishes, top coating materials, interior finishes, roof paints, iron paints, floor coverings, rooftop waterproofing materials, base adjustment coating materials, fireproof coating/insulation materials. The company was formerly known as Shikoku Kaken Industry Co., Ltd. and changed its name to Sk Kaken Co.,Ltd. in April 1991. Sk Kaken Co.,Ltd. was founded in 1955 and is headquartered in Ibaraki, Japan.

Full SKKAF Calculator →

GBDCBDC

Golub Capital BDC, Inc. (GBDC) is a business development company and operates as an externally managed closed-end non-diversified management investment company. It invests in debt and minority equity investments in middle-market companies that are, in most cases, sponsored by private equity investors. It typically invests in diversified consumer services, automobiles, healthcare technology, insurance, health care equipment and supplies, hotels, restaurants and leisure, healthcare providers and services, IT services and specialty retails. It seeks to invest in the United States. It primarily invests in first lien traditional senior debt, first lien one stop, junior debt and equity, senior secured, one stop, unitranche, second lien, subordinated and mezzanine loans of middle-market companies, and warrants.

Full GBDC Calculator →
📬

Get this SKKAF vs GBDC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SKKAF vs SCHDSKKAF vs JEPISKKAF vs OSKKAF vs KOSKKAF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.